Stroke

This channel includes news and new technology innovations for stroke. It includes both diagnosis and treatment of stroke, stroke imaging, pharmaceuticals and interventional stroke technologies. Stroke comes in two forms, which have different therapies.

1. Ischemic stoke is a blockage of an artery in the brain, preventing blood flow and is offen referred to as a "brain attack" because it is a similar casue as a heart attack. This type of stroke is often treated with anti-coagulants, including use of tissue plasminogen activator (tPA). Interventional mechanical thrombectomy can also be used to remove the clot.

2. Hemorrhagic stroke is caused when there is bleeding due to a ruptured blood vessel in the brain caused by a brain aneurysm burst or a weakened blood vessels. These strokes are less common, but exact diagnosis is important, because use of tPA in these patients can have catastrophic consequences. Treatments include interventional embolization and surgical clipping of target vessels. 

A 3-D CT reconstructed image showing a narrow lesion at the carotid bifurcation. ACST-2 was the largest trial to compare the long-term effect of carotid artery stenting (CAS) and carotid endarterectomy (CEA) on stroke in asymptomatic patients with a severely narrowed carotid artery that had not yet caused a stroke. Image by Canon

A 3-D CT reconstructed image showing a narrow lesion at the carotid bifurcation. ACST-2 was the largest trial to compare the long-term effect of carotid artery stenting (CAS) and carotid endarterectomy (CEA) on stroke in asymptomatic patients with a severely narrowed carotid artery that had not yet caused a stroke. Image by Canon

News | Stroke | September 07, 2021
Carotid Surgery Versus Stenting Have Similar Long-term Effects on Stroke
September 7, 2021 — Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke...
read more
The Robocath R-One cath lab robotic platform being used in Rouen, France, to guide a cardiac Cath procedure. The system gained European approval in 2019. Robocath is now partnering with Philips France and Rennes University Hospital to develop the robotic system to treat strokes.

The Robocath R-One cath lab robotic platform being used in Rouen, France, to guide a cardiac Cath procedure. The system gained European approval in 2019. Robocath is now partnering with Philips France and Rennes University Hospital to develop the robotic system to treat strokes.

News | Stroke | July 07, 2021
Robocath, Philips and Rennes University Hospital Codevelop Robotic Stroke Intervention System
July 7, 2021 – Robocath, a company that designs, develops and commercializes cath lab robotic solutions to treat...
read more
Videos | Robotic Systems | May 18, 2021
VIDEO: Interventional Stroke Care May be Aided by Robotic Cath Lab Telemedicine
Ehtisham Mahmud, M.D., division chief of cardiovascular medicine, director of interventional cardiology and the cardiac...
read more
The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE) have joined the International Contrast Ultrasound Society (ICUS) in recognizing the relatively low risk and important clinical benefits of ultrasound contrast agents (UCAs), which are used routinely around the world to help detect heart disease, stratify the risk of heart attack or stroke, identify and characterize tumors throughout the abdomen, and monitor the effectiveness of cancer therapies in adul
News | Contrast Media | May 11, 2021
Medical Societies Support Safety and Benefits of Ultrasound Contrast Agents
May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (...
read more
CDC and FDA Call for Pause on Janssen COVID-19 Vaccine Due to Rare Blood Clots #COVID19 #Janssen
Feature | Coronavirus (COVID-19) | April 13, 2021 | By Dave Fornell, Editor
CDC and FDA Call for Pause on Janssen COVID-19 Vaccine Due to Rare Blood Clots
(This story was updated May 7, 2021 in the last subheaded section) April 13, 2021 — The U.S. Food and Drug...
read more
Rapid Medical's TigerTrieve stent-retriever neuro thrombectomy system.

Rapid Medical's TigerTrieve stent-retriever neuro thrombectomy system.

News | Stroke | April 07, 2021
Thrombectomy Market Will Grow With Newly Approved Adjustable Stent Retriever
April 7, 2021 — Market research firm GlobalData's new report, Neurovascular Thrombectomy Devices (Neurology Devices),...
read more
Videos | Coronavirus (COVID-19) | April 01, 2021
VIDEO: Antithrombotic Prophylaxis in COVID-19 Patients
Behnood Bikdeli M.D., a cardiologist at the Brigham and Women’s Hospital, Harvard Medical School, Boston, offers an...
read more
Videos | Structural Heart | March 23, 2021
VIDEO: PFO Closure Shows Continued Stroke Prevention Benefit at 5 Years
Interview with Scott E. Kasner, M.D., who served as the principle investigator for the Gore Cardioform REDUCE trial,...
read more
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) can potentiate all 3 sides of Virchow’s Triad of coagulopathy, including endothelial dysfunction, blood flow stasis, and hypercoagulability. Angiotensin-converting enzyme-2 (ACE-2)–dependent viral entry and the virus-induced inflammatory response can lead to endothelial dysfunction. Clotting Prevention in COVID-19 Patients, Thrombosis Prevention in COVID-19 Patients, Preventing blood clots in COVID-19 patients

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) can potentiate all 3 sides of Virchow’s Triad of coagulopathy, including endothelial dysfunction, blood flow stasis and hypercoagulability. Angiotensin-converting enzyme-2 (ACE-2)–dependent viral entry and the virus-induced inflammatory response can lead to endothelial dysfunction. Additional figure included in the JACC article.

Feature | Antiplatelet and Anticoagulation Therapies | March 22, 2021 | By Dave Fornell, Editor
Overview of Trials for Anticoagulation Therapy for COVID-19 Patients
A comprehensive review or more than 80 randomized controlled trials (RCTs) investigating how to best manage optimal...
read more
Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al.

Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al. 

Feature | Coronavirus (COVID-19) | December 23, 2020
NIH Pauses Anticoagulant Trial For Critically Ill COVID-19 Patients
December 23, 2020 — Three clinical trial platforms working together to test the effects of full doses of anticoagulants...
read more
An example of a body composition analysis of an abdominal CT slice with the subcutaneous fat in green, skeletal muscle red and visceral fat in yellow. This was automatically identified and analyzed via a deep learning algorithm to assess the risk for heart attack and stroke in more than 12,000 patients. #RSNA2020 #RSNA20 #RSNA

An example of a body composition analysis of an abdominal CT slice with the subcutaneous fat in green, skeletal muscle red and visceral fat in yellow. This was automatically identified and analyzed via a deep learning algorithm to assess the risk for heart attack and stroke in more than 12,000 patients.

Feature | Artificial Intelligence | December 02, 2020
AI Measured Abdominal Fat Accurately Predicts Heart Attack and Stroke Risk
December 2, 2020 – Automated deep learning analysis of abdominal computed tomography (CT) images produces a more...
read more
Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging. #RSNA20 #RSNA2020

Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA Head triage AI solution will be offered by cloud-based imaging platform Arterys. Supporting the treatment of stroke and neurovascular emergencies, CINA Head detects intracranial hemorrhages (ICHs) and large vessel occlusions (LVOs) from CT-scan imaging.
 

News | Stroke | December 01, 2020
Arterys and Avicenna.AI Partner on AI Stroke Detection
December 1, 2020 – Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA...
read more
The NIH is heading three studies looking at various blood thinners and anticoagulants to treat COVID-19 patients with VTE.
News | Coronavirus (COVID-19) | September 11, 2020
NIH Trials Evaluate Various Blood Thinners to Treat COVID-19
September 11, 2020 — The National Institutes of Health (NIH) has launched two of three adaptive clinical trials...
read more
Examples of pulmonary embolism clots caused by COVID-19 seen on a chest CT. From the journal Radiology

Examples of pulmonary embolism clots caused by COVID-19 seen on a chest CT. From the journal Radiology

News | Coronavirus (COVID-19) | September 03, 2020
Possible Blood Clotting Mechanism in COVID-19 Found
September 3, 2020 — Why so many COVID-19 (SARS-CoV-2) patients get blood clots (thrombosis) remains uncertain. But...
read more
A carotid artery atherosclerotic plaque blockage at the bifurcation seen here can cause strokes. The stenting these lesions is a less invasive way of treating than open vessel surgery. The SVS has issued guidelines to help guide credentialing for the carotid stent procedure. Image from Vital Images.

A carotid artery atherosclerotic plaque blockage at the bifurcation seen here can cause strokes. The stenting these lesions is a less invasive way of treating than open vessel surgery. The SVS has issued guidelines to help guide credentialing for the carotid stent procedure. Image from Vital Images.

News | Stroke | July 09, 2020
Society for Vascular Surgery Outlines What is Needed for Trans-Carotid Artery Revascularization Training and Credentialing
July 9, 2020 — The Society for Vascular Surgery (SVS) has released a clinical competence statement on training and...
read more
© Copyright Wainscot Media. All Rights Reserved.